1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17412493

Cancer Lett. 2007 Aug 28 254 1 75-86

Download in:

View as

Triples

General Info

PMID
17412493